These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11064305)

  • 21. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defibrillation in the Brugada syndrome.
    Kadish A
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):267-8. PubMed ID: 15817084
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sudden death. Implantable defibrillators. Value of the technology and economic impact].
    Jazra C
    J Med Liban; 1999; 47(5):301-3. PubMed ID: 10887533
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The implantable cardioverter-defibrillator: does everybody need one?
    Raj SR; Sheldon RS
    Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

  • 27. Implantable cardioverter defibrillators.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):6-7. PubMed ID: 19172139
    [No Abstract]   [Full Text] [Related]  

  • 28. Implantable cardioverter/defibrillator therapy: the meaning of terms.
    Smith ER
    Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    ; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
    J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of high defibrillation threshold.
    Uyguanco ER; Berger A; Budzikowski AS; Gunsburg M; Kassotis J
    Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1237-48. PubMed ID: 18939911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chapter 3. Cost effectiveness of ICD therapy: a review of published evidence.
    O'Brien BJ
    Can J Cardiol; 2000 Oct; 16(10):1307-12. PubMed ID: 11064306
    [No Abstract]   [Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Vassanelli C
    Europace; 2004 May; 6(3):184-8. PubMed ID: 15121067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing an ICD support group. A framework.
    Vogt A
    Adv Nurse Pract; 2006 Sep; 14(9):59-60. PubMed ID: 16972447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.